Here are three things to know:
1. The meta-analysis encompassed 25 trials assessing the effect of invasive versus sham procedures in 2,000 participants. Invasive procedures had a 12 percent adverse event risk compared to a 4 percent risk for sham procedures among the 14 studies that reported on adverse events.
2. Authors concluded there is little evidence to determine that invasive procedures are more effective at treating chronic pain than sham procedures.
3. According to the authors, more research is needed before invasive procedures are routinely used for chronic pain treatment, given their high cost and relatively increased safety concerns.
More articles on orthopedics:
Southeast Georgia Health System welcomes orthopedic surgeon: 3 details
Orthopedic surgeon to know: Dr. James Bradley of Burke & Bradley Orthopedics
Colorado hospital lays-off orthopedic surgeon amid ‘financial recovery’: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.